Abstract
Abstract: Research on anxiety in later life has advanced significantly in the last two decades. Within the extant literature, there are both gaps and opportunities for further cross-disciplinary linkages in terms of the assessment, diagnosis, and treatment of late-life anxiety. Research across cultures and cohorts has increased our understanding of the experience of anxiety across groups and thus has advanced measurement efficacy and diagnostic accuracy. Work on addressing social determinants across the lifespan regarding anxiety symptoms and their sequelae may help address anxiety as a globally growing concern.
References
2007). Evidence-based psychological treatments for late-life anxiety. Psychology and Aging, 22(1), 8–17.
(2022). Making meaning of integrated care during a pandemic: Learning from older adults. The Clinical Gerontologist, 45(1), 172–188.
(2010). Double Jeopardy: Comorbid anxiety and depression in late life. Research in Gerontological Nursing, 3(3), 209–220.
(2008). Late-life anxiety and cognitive impairment: A review. The American Journal of Geriatric Psychiatry, 16(10), 790–803.
(1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893–897.
(2012). “Old people are cranky”: helping professional trainees’ knowledge, attitudes, aging anxiety, and interest in working with older adults. Educational Gerontology, 38(7), 465–472.
(2011). Development and validation of a short form of the Geriatric Anxiety Inventory–the GAI-SF. International Psychogeriatrics, 23(1), 125–131.
(2014). The clinical spectrum of anxiety in Parkinson’s disease. Movement Disorders, 29(8), 967–975.
(2016). Disease-specific anxiety symptomatology in Parkinson’s disease. International Psychogeriatrics, 28(7), 1153–1163.
(2017). Cognitive behaviour therapy for anxiety in Parkinson’s disease: Outcomes for patients and caregivers. Clinical Gerontologist, 40(3), 159–171.
(2021). Lessons in resilience: Initial coping among older adults during the COVID-19 pandemic. The Gerontologist, 61(1), 114–125.
(2012). Interventions for generalized anxiety disorder in older adults: Systematic review and meta-analysis. Journal of Anxiety Disorders, 26(1), 1–11.
(2014). Measuring anxiety in late life: A psychometric examination of the Geriatric Anxiety Inventory and Geriatric Anxiety Scale. Journal of Anxiety Disorders, 28(8), 804–811.
(2022). Climate anxiety, loneliness and perceived social isolation. International Journal of Environmental Research and Public Health, 19(22), Article
(14991 .2019). Anxiety in late life: An update on pathomechanisms. Gerontology, 65(5), 465–473.
(2021). Climate anxiety in children and young people and their beliefs about government responses to climate change: A global survey. The Lancet Planetary Health, 5(12), e863–e873.
(2019). The human imperative of stabilizing global climate change at 1.5 C. Science, 365(6459), Article
(eaaw6974 .1993). Measurement of aging anxiety: Development of the Anxiety About Aging Scale. The International Journal of Aging and Human Development, 37(4), 247–259.
(2020). Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Studies, 44(7), 393–401.
(2001). Comorbidity of depression and anxiety disorders in later life. Depression and Anxiety, 14(2), 86–93.
(2011). A lifespan view of anxiety disorders. Dialogues in Clinical Neuroscience, 13(4), 381–399.
(2022). Breaking the age code. Random House.
(2020). Ageism amplifies cost and prevalence of health conditions. The Gerontologist, 60(1), 174–181.
(2002). Longevity increased by positive self-perceptions of aging. Journal of Personality and Social Psychology, 83(2), 261–270.
(2019). Item response analysis of the Geriatric Anxiety Inventory among the elderly in China: Dimensionality and differential item functioning test. BMC Geriatrics, 19(1), 1–9.
(2000). Exploratory analyses of the latent structure of anxiety among older adults. Educational and Psychological Measurement, 60, 100–116.
(2021). Risk-taking, resilience, and state anxiety during the COVID-19 pandemic: A coming of (old) age story. Personality and Individual Differences, 170, Article
(110485 .2012). Psychometric properties of the Spanish version of the Geriatric Anxiety Inventory. International Psychogeriatrics, 24(1), 137–144.
(2011). Translation and cross-cultural adaptation of the Brazilian version of the Geriatric Anxiety Inventory (GAI). Revista de Psiquiatria Clínica, 38(1), 8–12.
(2015). Validation of the Brazilian Portuguese version of Geriatric Anxiety Inventory – GAI-BR. International Psychogeriatrics, 27(7), 1113–1119.
(2012). Validity and reliability of the Geriatric Anxiety Inventory in Parkinson’s disease patients. Australasian Journal on Ageing, 31(1), 13–16.
(2014). Age-related changes in Generalized Anxiety Disorder symptoms. International Psychogeriatrics, 26(4), 565–572.
(2014). Social phobia symptoms across the adult lifespan. Journal of Affective Disorders, 168, 86–90.
(2015). Threshold and subthreshold Generalized Anxiety Disorder in later life. American Journal of Geriatric Psychiatry, 23(6), 633–641.
(2012). Improving recognition of late life anxiety disorders in Diagnostic and Statistical Manual of Mental Disorders: Observations and recommendations of the Advisory Committee to the Lifespan Disorders Work Group. International Journal of Geriatric Psychiatry, 27(6), 549–556.
(2017). A bifactor and item response analysis of the Geriatric Anxiety Inventory. International Psychogeriatrics, 29(10), 1647–1656.
(2020). A cross-national analysis of the psychometric properties of the Geriatric Anxiety Inventory (GAI). Journals of Gerontology: Psychological Sciences, 75(7), 1475–1483.
(1970). Gerontology: Public anxiety about ageing. Nature, 226, 895–896. https://doi.org/10.1038/226895a0
. (2020). Covid-19 and psychogeriatrics: The view from Australia. International Psychogeriatrics, 32(10), 1135–1141.
(2007). Development and validation of the Geriatric Anxiety Inventory. International Psychogeriatrics, 19, 103–114.
(2013). Clinical issues in the treatment of anxiety and depression in older adults with Parkinson’s Disease. Movement Disorders, 28(14), 1930–1934.
(2012). Anxiety and depression in adults in their eighties: Do gender differences remain? International Psychogeriatrics, 24(1), 145–150.
(2022). Healthy aging: Current and future frameworks and developments. Reference Module in Neuroscience and Biobehavioral Psychology.
(2018). Anxiety disorders in late life. Psychiatric Clinics, 41(1), 55–64.
(2020). Cognitive-behavioral therapy for anxiety in Parkinson’s disease. Behavior Modification, 44(4), 552–579.
(2011). Portuguese version of the Geriatric Anxiety Inventory: Transcultural adaptation and psychometric validation. Aging & Mental Health, 15(6), 742–748.
(2022). Prevalence of prodromal symptoms of Parkinson’s disease in the late middle-aged population. Journal of Parkinson’s Disease, 12(3), 967–974.
(2023). Culturally appropriate assessment of depression and anxiety in older Torres Strait Islanders: Limitations and recommendations. Clinical Geropsychologist, 46(2), 240–252.
(2010). Development and initial validation of a self-report assessment tool for anxiety among older adults: The Geriatric Anxiety Scale. Journal of Anxiety Disorders, 24(7), 709–714.
(1999). The development of a valid and reliable scale for rating anxiety in dementia (RAID). Aging & Mental Health, 3(1), 39–49.
(2021). Psychometric properties of the Persian version of the Geriatric Anxiety Inventory (GAI-PV) and its short form. Medical Journal of the Islamic Republic of Iran, 35, Article
(47 . https://doi.org/10.47176/mjiri.35.472011). Late-life anxiety disorders: A review. Current Psychiatry Reports, 13(4), 267–273.
(2019). Cognitive behavioural therapy can be effective in treating anxiety and depression in persons with dementia: A systematic review. Psychogeriatrics, 19(3), 264–275.
(2009). Meta-analysis comparing different behavioral treatments for late-life anxiety. The American Journal of Geriatric Psychiatry, 17(2), 105–115.
(2019). Nonpharmacological interventions for anxiety and dementia in nursing homes: A systematic review. The Gerontologist, 59(6), e731–e742.
(2021). Global report on ageism. WHO.
. (2021). Virtual reality-assisted cognitive behavioral therapy for anxiety disorders: A systematic review and meta-analysis. Frontiers in Psychiatry, 12, Article
(575094 .2019). Telephone-delivered cognitive behavioural therapy for treating symptoms of anxiety and depression in Parkinson’s disease: A pilot trial. Clinical Gerontologist, 42(4), 444–453.
(2020). Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of Affective Disorders, 277, 55–64.
(1983). Development and validation of a Geriatric Depression Screening Scale: A preliminary report. Journal of Psychiatric Research, 17, 37–49.
(